Shortened length of hospital stay with rivaroxaban in patients with symptomatic venous thromboembolism in Japan: the J-EINSTEIN pulmonary embolism and deep vein thrombosis program

Hiroshi Matsuo*, Martin Prins, Anthonie W. A. Lensing, Emi Watanabe Fujinuma, Yuki Miyamoto, Mariko Kajikawa

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

15 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1057-1061
JournalCurrent Medical Research and Opinion
Issue number6
Publication statusPublished - Jun 2015


  • Deep vein thrombosis
  • Japan
  • Length of stay
  • Pulmonary embolism
  • Randomized trial
  • Rivaroxaban
  • Unfractionated heparin
  • Venous thromboembolism
  • Warfarin

Cite this